Sustainability Report

Overview

The report describes the company's 2025 progress in sustainable access to medicines, including supply to approximately 1 billion patients worldwide. It reports a 17% reduction in Scope 1 and 2 emissions and a 36% reduction in Scope 3 emissions against the 2020 base year. The company also reports 17 zero-waste-to-landfill sites, exceeding its 2030 target, alongside broad people, water and community initiatives.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Publication date: 21 May 2026
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status
CDP score

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services